What the world needs now is strength.

Liz Haberkorn, Zubin Austin, Cynthia Knapp Dlugosz, and Suzanne Harris

The stories of the pharmacists and pharmacy technicians who served patients and communities during the COVID-19 pandemic are crucial to staying prepared for health crises of the future.

Rachel Balick

Keep an eye out in your practice for the top 10 medication errors reported to the Institute for Safe Medication Practices (ISMP) in 2019.

Rachel Balick

Health experts can agree that one of the silver linings of the COVID-19 pandemic is the way it has propelled telehealth forward.

Loren Bonner

Digital pharmacy models such as Capsule and Amazon’s PillPack have entered the marketplace to offer patients a pharmacy experience built on convenience.

Maria G. Tanzi, PharmD

Marijuana use has increased, with millions of Americans using the drug both medicinally and recreationally.

Maria G. Tanzi, PharmD

In the midst of the COVID-19 global pandemic, the opioid epidemic in the United States rages on.

Sonya Collins

In January, the Surgeon General released the first report on smoking cessation in 30 years.

Aina Abell

Cholecalciferol, a fat-soluble compound also known as vitamin D3, is one of two forms of vitamin D used to treat and prevent vitamin D deficiency and associated diseases, such as rickets.

Mary Warner

Summer is just around the corner, which means more folks will spend more time in the sun.

Daniel L. Krinsky, RPh, MS

Updates from FDA

Trending Topics in Health-System Pharmacy

Transitions of care are fraught with risk for patients.

Joey Sweeney, PharmD, BCPS

Chemotherapy continues to be the predominant treatment for patients with cancer. Although the benefit-to-risk ratio of chemotherapy medications is favorable for these patients, health care workers preparing, transporting, and administering these drugs are exposed to workplace health risk.

Joey Sweeney, PharmD, BCPS

Central line–associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and Clostridioides difficile infections all declined between 2017 and 2018 across four health care settings, according to CDC’s National and State Healthcare-Associated Infections Progress Report, released in November 2019.

Maria G. Tanzi, PharmD

In late February, the Institute for Safe Medication Practices (ISMP) released its 2020–2021 consensus-based medication safety best practices for hospitals.

Maria G. Tanzi, PharmD

Part 1 (Pharmacy Today, December 2019) of this series on new FDA-approved therapeutic agents marketed in 2019 reviewed eight new therapeutic agents: omadacycline tosylate (Nuzyra—Paratek), sarecycline hydrochloride (Seysara—Almirall), lefamulin acetate (Xenleta—Nabriva), rifamycin sodium (Aemcolo—Aries), prucalopride succinate (Motegrity—Shire), romosozumab-aqqg (Evenity—Amgen), upadacitinib (Rinvoq—AbbVie), and risankizumab-rzaa (Skyrizi—AbbVie).

Daniel A. Hussar, PhD, FAPhA

APhA Member News

Take the Crossword Challenge

Living with multiple chronic conditions, including diabetes, kidney failure, heart failure, seizures, HIV, and depression, “Laura” takes dozens of medications.

Sonya Collins

Many adverse events can occur following an error by a pharmacist, yet eventually the consequences for a patient can become so disconnected that the chain of causation will break, and there will be no pharmacist liability.

David B. Brushwood, BSPharm, JD

Hospital and community compounding pharmacists will have more flexibility thanks to FDA guidances aimed at easing drug shortages during the COVID-19 pandemic.

Rachel Balick